Canopy Biosciences

Canopy Biosciences

Canopy Biosciences

Canopy Biosciences aims to accelerate the commercialization of life science reagent tools and services through in-licensing.
Founded
2016
Raised
$4.4M
Follow us
Alexa global traffic share
Latest funding Show all
Undisclosed amount
Venture capital - 2019
Ampersand Capital Partners
$2,400,000
Venture capital (Series A) - 2018
BioGenerator Kingdom Capital
Team Size
10+
Employees
FinSMEs

Canopy Biosciences Acquires Zellkraftwerk

PE HUB

PE-backed Canopy Biosciences buys Zellkraftwerk

$2,400,000 Venture capital (Series A)
PE HUB , FinSMEs

Canopy Biosciences takes in $2.4 mln Series A

Data leaks Messaging